Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$793
|
$747B |
14.1x |
35.1x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$192
|
$405B |
6.9x |
15.3x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$157
|
$391B |
4.3x |
11.9x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$295
|
$207B |
6.0x |
11.1x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$110
|
$153B |
5.3x |
12.1x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$135B |
2.9x |
10.6x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$469
|
$116B |
10.1x |
35.3x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$155
|
$74.0B |
7.9x |
18.3x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$568
|
$55.7B |
4.0x |
11.3x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$315
|
$39.7B |
15.2x |
218.0x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$24.2B |
1.7x |
5.6x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$134
|
$23.7B |
2.5x |
7.4x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$98
|
$18.6B |
44.6x |
-20.2x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$25
|
$18.2B |
N/A |
-70.2x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$133
|
$12.7B |
5.0x |
21.0x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$113
|
$10.9B |
4.1x |
-7.5x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$69
|
$10.9B |
2.4x |
16.2x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$58
|
$10.5B |
3.5x |
13.5x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$296
|
$10.2B |
3.3x |
6.3x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$46
|
$10.1B |
29.3x |
-21.6x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$110
|
$9.5B |
2.3x |
7.2x |
Blueprint Medicines
|
United States of America |
Drug Development & Therapeutics
|
$129
|
$8.2B |
13.3x |
-77.5x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$57
|
$7.8B |
6.9x |
10.8x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$34
|
$7.8B |
3.0x |
-2.0x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$72
|
$7.3B |
9.2x |
N/A |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$7.3B |
N/A |
N/A |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$39
|
$6.5B |
7.8x |
-43.8x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$315
|
$6.3B |
14.1x |
-14.4x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$42
|
$5.9B |
8.1x |
-13.1x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$5.8B |
12.5x |
52.9x |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$87
|
$5.5B |
35.8x |
-25.4x |
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$81
|
$5.3B |
3.4x |
7.8x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$109
|
$5.3B |
10.5x |
-28.8x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$5.1B |
1.8x |
7.9x |
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$5.1B |
807.9x |
-6.1x |
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$81
|
$4.7B |
N/A |
-14.8x |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$4.3B |
209.9x |
-7.2x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$30
|
$4.2B |
2.9x |
11.1x |
Soleno Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$82
|
$4.1B |
103.3x |
N/A |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$3.8B |
6.6x |
21.3x |
Endo
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$21
|
$3.7B |
N/A |
N/A |
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$148
|
$3.7B |
10.5x |
27.8x |
Merus
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$3.6B |
76.6x |
-12.3x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$39
|
$3.5B |
N/A |
N/A |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$3.5B |
N/A |
N/A |
Akero Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$52
|
$3.5B |
N/A |
-10.9x |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$39
|
$3.4B |
33.4x |
-44.0x |
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$69
|
$3.3B |
38.3x |
-17.6x |
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$57
|
$3.3B |
83.5x |
-7.2x |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$3.3B |
859.7x |
-11.5x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$2.9B |
50.6x |
N/A |
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$11
|
$2.9B |
101.7x |
-2.8x |
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$2.9B |
2.8x |
18.5x |
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$44
|
$2.7B |
42.8x |
-10.5x |
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$53
|
$2.7B |
11.1x |
53.0x |
MoonLake
|
United States of America |
Drug Development & Therapeutics
|
$49
|
$2.7B |
N/A |
-15.3x |
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$53
|
$2.6B |
6.7x |
-50.5x |
Viking Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$2.6B |
3381.5x |
-14.5x |
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$2.6B |
1.2x |
13.4x |
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$19
|
$2.6B |
3.3x |
-18.4x |
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$2.4B |
276.6x |
-5.3x |
Immunovant
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$2.4B |
878.6x |
-5.3x |
Ultragenyx
|
United States of America |
Drug Development & Therapeutics
|
$30
|
$2.3B |
3.8x |
-5.0x |
BioCryst Pharma
|
United States of America |
Drug Development & Therapeutics
|
$9
|
$2.3B |
4.4x |
45.2x |
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$49
|
$2.2B |
1.7x |
6.0x |
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$122
|
$2.1B |
11.8x |
37.0x |
Catalyst Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$2.1B |
4.0x |
8.8x |
Vericel
|
United States of America |
Regenerative Medicine,
Drug Development & Therapeutics
|
$40
|
$2.0B |
7.6x |
31.1x |
Phibro Animal Health
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$1.9B |
1.5x |
10.2x |
Xenon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$32
|
$1.9B |
489.8x |
-6.3x |
Certara
|
United States of America |
Health Data & Analytics,
Drug Development & Therapeutics
|
$11
|
$1.9B |
4.8x |
15.2x |
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$63
|
$1.9B |
N/A |
N/A |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$65
|
$1.9B |
2.7x |
10.5x |
Recursion Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Bioinformatics
|
$5
|
$1.9B |
28.9x |
-3.8x |
BGM Group
|
United States of America |
Drug Development & Therapeutics
|
$9
|
$1.8B |
N/A |
N/A |
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$1.8B |
3.2x |
-36.7x |
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$28
|
$1.8B |
3.5x |
162.1x |
Crinetics Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$32
|
$1.8B |
542.3x |
-4.6x |
Apogee Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$1.7B |
N/A |
-6.8x |
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$1.7B |
6.6x |
-18.2x |
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$33
|
$1.7B |
2.4x |
4.0x |
Adaptive Biotech
|
United States of America |
Pharma Diagnostics & Analytics,
Drug Development & Therapeutics
|
$12
|
$1.7B |
8.5x |
-27.6x |
Harmony Biosciences Hldgs
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$1.6B |
2.1x |
6.1x |
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$22
|
$1.6B |
50.2x |
N/A |
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$1.5B |
4.9x |
-10.8x |
Ocular Therapeutix
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$11
|
$1.5B |
24.9x |
-7.4x |
ARS Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$18
|
$1.5B |
17.4x |
-486.6x |
Harrow
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$35
|
$1.4B |
5.9x |
24.9x |
Amphastar Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$22
|
$1.4B |
2.0x |
5.3x |
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$33
|
$1.4B |
2.2x |
8.3x |
Agios Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$39
|
$1.4B |
35.2x |
-3.2x |
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$1.4B |
N/A |
-6.3x |
CG Oncology
|
United States of America |
Drug Development & Therapeutics
|
$27
|
$1.3B |
738.1x |
-9.1x |
Denali Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$1.3B |
108.5x |
-2.7x |
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$1.3B |
4.4x |
-16.1x |
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$57
|
$1.3B |
N/A |
-8.0x |
IDEAYA Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$1.3B |
124.6x |
-4.0x |
Pacira BioSciences
|
United States of America |
Drug Development & Therapeutics,
Medical Devices
|
$23
|
$1.2B |
1.7x |
5.7x |
Innoviva
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$19
|
$1.2B |
3.3x |
N/A |
Liquidia
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$14
|
$1.2B |
42.6x |
N/A |